Experiment Overview
| Repository ID: | FR-FCM-Z2VG | Experiment name: | Human mass cytometry immune phenotyping in diffuse large B-cell lymphoma (DLBCL) | MIFlowCyt score: | 27.58% |
| Primary researcher: | Eivind Heggernes Ask | PI/manager: | Eivind Heggernes Ask | Uploaded by: | Eivind Heggernes Ask |
| Experiment dates: | 2017-05-05 - | Dataset uploaded: | Sep 2020 | Last updated: | May 2023 |
| Keywords: | [diffuse large B-cell lymphoma] [human PBMC] [mass cytometry] | Manuscripts: | [35590201] | ||
| Organizations: |
Oslo University Hospital, Oslo, (Norway)
|
||||
| Purpose: | Immune phenotyping of peripheral blood mononuclear cells (PBMCs) from patients with diffuse large B-cell lymphoma using a broad mass cytometry (CyTOF) panel. Samples from the 28 included patients were taken at the time of diagnosis, before initiation of treatment, and compared with 17 healthy blood donors. | ||||
| Conclusion: | None | ||||
| Comments: | Data was gated on single, viable CD45+ cells. Please refer to the published article for technical information and interpretation of the data. | ||||
| Funding: | Not disclosed | ||||
| Quality control: | None | ||||
Experiment variables
| Conditions | |
|---|---|
| · healthy controls | DLBCL_P1_CD45_healthy_1.fcs · DLBCL_P1_CD45_healthy_10.fcs · DLBCL_P1_CD45_healthy_11.fcs · DLBCL_P1_CD45_healthy_12.fcs · DLBCL_P1_CD45_healthy_13.fcs · DLBCL_P1_CD45_healthy_14.fcs · DLBCL_P1_CD45_healthy_15.fcs · DLBCL_P1_CD45_healthy_16.fcs · DLBCL_P1_CD45_healthy_17.fcs · DLBCL_P1_CD45_healthy_2.fcs · DLBCL_P1_CD45_healthy_3.fcs · DLBCL_P1_CD45_healthy_4.fcs · DLBCL_P1_CD45_healthy_5.fcs · DLBCL_P1_CD45_healthy_6.fcs · DLBCL_P1_CD45_healthy_7.fcs · DLBCL_P1_CD45_healthy_8.fcs · DLBCL_P1_CD45_healthy_9.fcs |
| · patients | DLBCL_P1_CD45_patient_18.fcs · DLBCL_P1_CD45_patient_19.fcs · DLBCL_P1_CD45_patient_20.fcs · DLBCL_P1_CD45_patient_21.fcs · DLBCL_P1_CD45_patient_22.fcs · DLBCL_P1_CD45_patient_23.fcs · DLBCL_P1_CD45_patient_24.fcs · DLBCL_P1_CD45_patient_25.fcs · DLBCL_P1_CD45_patient_26.fcs · DLBCL_P1_CD45_patient_27.fcs · DLBCL_P1_CD45_patient_28.fcs · DLBCL_P1_CD45_patient_29.fcs · DLBCL_P1_CD45_patient_30.fcs · DLBCL_P1_CD45_patient_31.fcs · DLBCL_P1_CD45_patient_32.fcs · DLBCL_P1_CD45_patient_33.fcs · DLBCL_P1_CD45_patient_34.fcs · DLBCL_P1_CD45_patient_35.fcs · DLBCL_P1_CD45_patient_36.fcs · DLBCL_P1_CD45_patient_37.fcs · DLBCL_P1_CD45_patient_38.fcs · DLBCL_P1_CD45_patient_39.fcs · DLBCL_P1_CD45_patient_40.fcs · DLBCL_P1_CD45_patient_41.fcs · DLBCL_P1_CD45_patient_42.fcs · DLBCL_P1_CD45_patient_43.fcs · DLBCL_P1_CD45_patient_44.fcs · DLBCL_P1_CD45_patient_45.fcs |
| Sample Type | |
|---|---|
| · PBMC | DLBCL_P1_CD45_healthy_1.fcs · DLBCL_P1_CD45_healthy_10.fcs · DLBCL_P1_CD45_healthy_11.fcs · DLBCL_P1_CD45_healthy_12.fcs · DLBCL_P1_CD45_healthy_13.fcs · DLBCL_P1_CD45_healthy_14.fcs · DLBCL_P1_CD45_healthy_15.fcs · DLBCL_P1_CD45_healthy_16.fcs · DLBCL_P1_CD45_healthy_17.fcs · DLBCL_P1_CD45_healthy_2.fcs · DLBCL_P1_CD45_healthy_3.fcs · DLBCL_P1_CD45_healthy_4.fcs · DLBCL_P1_CD45_healthy_5.fcs · DLBCL_P1_CD45_healthy_6.fcs · DLBCL_P1_CD45_healthy_7.fcs · DLBCL_P1_CD45_healthy_8.fcs · DLBCL_P1_CD45_healthy_9.fcs · DLBCL_P1_CD45_patient_18.fcs · DLBCL_P1_CD45_patient_19.fcs · DLBCL_P1_CD45_patient_20.fcs · DLBCL_P1_CD45_patient_21.fcs · DLBCL_P1_CD45_patient_22.fcs · DLBCL_P1_CD45_patient_23.fcs · DLBCL_P1_CD45_patient_24.fcs · DLBCL_P1_CD45_patient_25.fcs · DLBCL_P1_CD45_patient_26.fcs · DLBCL_P1_CD45_patient_27.fcs · DLBCL_P1_CD45_patient_28.fcs · DLBCL_P1_CD45_patient_29.fcs · DLBCL_P1_CD45_patient_30.fcs · DLBCL_P1_CD45_patient_31.fcs · DLBCL_P1_CD45_patient_32.fcs · DLBCL_P1_CD45_patient_33.fcs · DLBCL_P1_CD45_patient_34.fcs · DLBCL_P1_CD45_patient_35.fcs · DLBCL_P1_CD45_patient_36.fcs · DLBCL_P1_CD45_patient_37.fcs · DLBCL_P1_CD45_patient_38.fcs · DLBCL_P1_CD45_patient_39.fcs · DLBCL_P1_CD45_patient_40.fcs · DLBCL_P1_CD45_patient_41.fcs · DLBCL_P1_CD45_patient_42.fcs · DLBCL_P1_CD45_patient_43.fcs · DLBCL_P1_CD45_patient_44.fcs · DLBCL_P1_CD45_patient_45.fcs |
| Timepoints | |
|---|---|
| · before treatment | DLBCL_P1_CD45_patient_18.fcs · DLBCL_P1_CD45_patient_19.fcs · DLBCL_P1_CD45_patient_20.fcs · DLBCL_P1_CD45_patient_21.fcs · DLBCL_P1_CD45_patient_22.fcs · DLBCL_P1_CD45_patient_23.fcs · DLBCL_P1_CD45_patient_24.fcs · DLBCL_P1_CD45_patient_25.fcs · DLBCL_P1_CD45_patient_26.fcs · DLBCL_P1_CD45_patient_27.fcs · DLBCL_P1_CD45_patient_28.fcs · DLBCL_P1_CD45_patient_29.fcs · DLBCL_P1_CD45_patient_30.fcs · DLBCL_P1_CD45_patient_31.fcs · DLBCL_P1_CD45_patient_32.fcs · DLBCL_P1_CD45_patient_33.fcs · DLBCL_P1_CD45_patient_34.fcs · DLBCL_P1_CD45_patient_35.fcs · DLBCL_P1_CD45_patient_36.fcs · DLBCL_P1_CD45_patient_37.fcs · DLBCL_P1_CD45_patient_38.fcs · DLBCL_P1_CD45_patient_39.fcs · DLBCL_P1_CD45_patient_40.fcs · DLBCL_P1_CD45_patient_41.fcs · DLBCL_P1_CD45_patient_42.fcs · DLBCL_P1_CD45_patient_43.fcs · DLBCL_P1_CD45_patient_44.fcs · DLBCL_P1_CD45_patient_45.fcs |
